baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UBS Knock-Out VRTX/ DE000UK2V6K0 /

10/7/2024 7:33:06 PM	Chg.-0.040	Bid9:54:03 PM	Ask9:54:03 PM	Underlying	Strike price	Expiration date	Option type
1.160EUR	-3.33%	- Bid Size: -	- Ask Size: -	Vertex Pharmaceutica...	326.438 USD	12/31/2078	Call

GlobeNewswire 8/13 Entrada Therapeutics Reports Second Quarter 2024 Financial Results

GlobeNewswire 8/9 ProKidney Reports Business Updates and Second Quarter 2024 Financial Results

GlobeNewswire 8/7 Editas Medicine Announces Second Quarter 2024 Results and Business Updates

GlobeNewswire 8/5 Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business Update

GlobeNewswire 8/5 CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

Newsfile Corp 7/17 Analysts Hunt for Undervalued Biotech Stocks

Newsfile Corp 7/11 Biopharma Stocks Transformative Innovation for the Future of Health

GlobeNewswire 7/9 Payscale Expands Data & Technology Resources, Powering Decision-Focused Compensation Management

GlobeNewswire 7/9 Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors

GlobeNewswire 6/28 Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Di...

GlobeNewswire 6/10 Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as C...

GlobeNewswire 5/29 CRISPR Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire 5/23 CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments

GlobeNewswire 5/15 Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 5/9 CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference

GlobeNewswire 5/8 CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

GlobeNewswire 5/8 CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo ...

GlobeNewswire 5/8 Editas Medicine Announces First Quarter 2024 Results and Business Updates

GlobeNewswire 5/7 Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 4/30 American Kidney Fund Encourages People to Be APOL1 Aware with First Annual APOL1-Mediated Kidney Dis...

GlobeNewswire 4/27 SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLC Investigates MODN, AIRC, INRD, ALPN

GlobeNewswire 4/25 American Kidney Fund Launches National Kidney Health Equity Media Campaign

GlobeNewswire 4/22 TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - ALPN, LABP, SWAV, FUS...

GlobeNewswire 4/22 CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASG...

GlobeNewswire 4/22 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INRD, AIRC, ELYM, ALPN

UBS Knock-Out VRTX/ DE000UK2V6K0 /

If you wish to receive reply to your feedback, please provide your email address.